- Home
- FRD vs XBIT Comparison
FRD vs XBIT Comparison
Compare FRD & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRD
- XBIT
- Stock Information
- Founded
- FRD 1965
- XBIT 2005
- Country
- FRD United States
- XBIT United States
- Employees
- FRD N/A
- XBIT N/A
- Industry
- FRD Steel/Iron Ore
- XBIT Pharmaceuticals and Biotechnology
- Sector
- FRD Industrials
- XBIT Health Care
- Exchange
- FRD Nasdaq
- XBIT Nasdaq
- Market Cap
- FRD 119.5M
- XBIT 105.2M
- IPO Year
- FRD N/A
- XBIT 2015
- Fundamental
- Price
- FRD $16.17
- XBIT $2.85
- Analyst Decision
- FRD
- XBIT
- Analyst Count
- FRD 0
- XBIT 0
- Target Price
- FRD N/A
- XBIT N/A
- AVG Volume (30 Days)
- FRD 20.1K
- XBIT 61.1K
- Earning Date
- FRD 06-10-2025
- XBIT 05-20-2025
- Dividend Yield
- FRD 1.00%
- XBIT N/A
- EPS Growth
- FRD N/A
- XBIT N/A
- EPS
- FRD 0.81
- XBIT N/A
- Revenue
- FRD $447,616,000.00
- XBIT N/A
- Revenue This Year
- FRD N/A
- XBIT N/A
- Revenue Next Year
- FRD N/A
- XBIT N/A
- P/E Ratio
- FRD $19.70
- XBIT N/A
- Revenue Growth
- FRD N/A
- XBIT N/A
- 52 Week Low
- FRD $12.24
- XBIT $2.65
- 52 Week High
- FRD $19.18
- XBIT $9.45
- Technical
- Relative Strength Index (RSI)
- FRD 48.38
- XBIT 44.14
- Support Level
- FRD $14.00
- XBIT $2.65
- Resistance Level
- FRD $17.73
- XBIT $3.08
- Average True Range (ATR)
- FRD 0.74
- XBIT 0.21
- MACD
- FRD -0.14
- XBIT -0.01
- Stochastic Oscillator
- FRD 58.18
- XBIT 29.85
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.